Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers and Outcomes in patients with COVID-19: A Systematic Review and Meta-Analysis.
CONCLUSION: use of ACEI/ARB was not associated with increased mortality or severe COVID-19.
PMID: 32945216 [PubMed - as supplied by publisher]
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research
More News: Cardiology | Cardiovascular | Coronavirus | COVID-19 | Databases & Libraries | Heart | Study